Ra Medical Systems Shows Record Second Quarter Sales and Profits
Carlsbad, CA – July 7 – Ra Medical Systems announced today that it had record second quarter sales and profits. The announcement was based on un-audited financial statements that do not accompany the press release.
Commenting on the success, Dean Irwin, Chief Executive of Ra Medical Systems, said, "We continue to have profitable quarters and these results are indicative of the future trend. Ra Medical has insignificant debt, cost-effective manufacturing, and good profit margins. Our well-established production capabilities and high customer satisfaction speak for our product quality and successful clinical outcomes. Recent contracts and sales in international markets only help to ensure our continued success."
Stephan Beal, Ra Medical’s Vice President of Sales, added “The continued demand for the PHAROS laser from dermatologists in the US and internationally reflects that 308-nm laser therapy has come of age and is now a standard of care for psoriasis and vitiligo. Customers are confident in investing in PHAROS technology, knowing they will have high demand for the treatment and create a strong profit center for their practice.”
Ra Medical Systems will exhibit at the upcoming annual summer meeting of the American Academy of Dermatology in Boston, Mass, July 21 through July 24.
For more information please call investor relations at 760-804-1648.
SOURCE: Ra Medical Systems, Inc
This media release may contain forward-looking statements regarding, but not limited to, clinical studies and results of those studies, management, market potential, distributor success, market size, international approvals, FDA clearances, marketing, future events and performance of the company, which involve risks and uncertainties that could materially affect actual results. Certain factors could cause actual results to vary from current expectations and the forward-looking statements contained in this media release.
|
